Steward Partners Investment Advisory’s Virtus Biotech ETF BBP Stock Holding History

Steward Partners Investment Advisory’s Portfolio BBP Stock Details BBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$11.1K	Buy	+115	New	+$10K	﹤0.01%	3684

Other funds holding BBP

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

CAMG

CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Cetera Investment Advisers Schaumburg, Illinois $110B AUM 26.29% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

WBI Investments Red Bank, New Jersey $403M AUM 42.23% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

PCIA

Prime Capital Investment Advisors Overland Park, Kansas $10.3B AUM 25.54% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Steward Partners Investment Advisory's BBP Position: Q2 2026 in Review

Steward Partners Investment Advisory opened a new position in Virtus Biotech ETF (BBP) in Q2 2026: 115 shares worth $11.1K. The stake represents ﹤0.01% of the portfolio and ranks #3684 among its holdings.

23 funds tracked by Wall St. Rank hold BBP as of Q2 2026.

Steward Partners Investment Advisory held 115 shares of Virtus Biotech ETF worth $11.1K as of Q2 2026.
Virtus Biotech ETF was a new Steward Partners Investment Advisory position in Q2 2026.
Virtus Biotech ETF made up ﹤0.01% of Steward Partners Investment Advisory's portfolio in Q2 2026, its #3684 holding.
23 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q2 2026.

Based on Steward Partners Investment Advisory's 13F filing for Q2 2026, filed 13 Aug 2026.